Barclays’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,760
| Closed | -$47K | – | 5500 |
|
|
2021
Q4 | $47K | Buy |
+1,760
| New | +$53.1K | ﹤0.01% | 3849 |
|
|
2019
Q1 | – | Sell |
-200
| Closed | -$5K | – | 7279 |
|
|
2018
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 6450 |
|
|
2018
Q3 | $6K | Hold |
200
| – | – | ﹤0.01% | 6758 |
|
|
2018
Q2 | $6K | Hold |
200
| – | – | ﹤0.01% | 6682 |
|
|
2018
Q1 | $7K | Sell |
200
-2,000
| -91% | -$80.1K | ﹤0.01% | 6732 |
|
|
2017
Q4 | $85K | Sell |
2,200
-20
| -0.9% | -$761 | ﹤0.01% | 5368 |
|
|
2017
Q3 | $57K | Hold |
2,220
| – | – | ﹤0.01% | 5285 |
|
|
2017
Q2 | $61K | Buy |
+2,220
| New | +$60.8K | ﹤0.01% | 5237 |
|
|
2017
Q1 | – | Sell |
-1,170
| Closed | -$28K | – | 6952 |
|
|
2016
Q4 | $28K | Buy |
1,170
+50
| +4% | +$1.43K | ﹤0.01% | 5468 |
|
|
2016
Q3 | $41K | Buy |
1,120
+980
| +700% | +$28.1K | ﹤0.01% | 5089 |
|
|
2016
Q2 | $3K | Buy |
140
+60
| +75% | +$1.49K | ﹤0.01% | 5871 |
|
|
2016
Q1 | $2K | Sell |
80
-80
| -50% | -$1.97K | ﹤0.01% | 5882 |
|
|
2015
Q4 | $5K | Buy |
+160
| New | +$4.85K | ﹤0.01% | 5576 |
|
|
2015
Q2 | – | Sell |
-130
| Closed | -$4K | – | 7189 |
|
|
2015
Q1 | $4K | Sell |
130
-10
| -7% | -$274 | ﹤0.01% | 6694 |
|
|
2014
Q4 | $3K | Hold |
140
| – | – | ﹤0.01% | 7069 |
|
|
2014
Q3 | $1K | Sell |
140
-1,230
| -90% | -$34.7K | ﹤0.01% | 7524 |
|
|
2014
Q2 | $41K | Buy |
1,370
+180
| +15% | +$6.12K | ﹤0.01% | 6084 |
|
|
2014
Q1 | $36K | Buy |
1,190
+760
| +177% | +$27.1K | ﹤0.01% | 6259 |
|
|
2013
Q4 | $9K | Sell |
430
-340
| -44% | -$9.98K | ﹤0.01% | 7032 |
|
|
2013
Q3 | $23K | Sell |
770
-1,580
| -67% | -$57.7K | ﹤0.01% | 6467 |
|
|
2013
Q2 | $78K | Buy |
+2,350
| New | +$106K | ﹤0.01% | 5995 |
|
Other funds holding RIGL
AC
VCM
